Auris Huen

1.4k citations
75 papers · 841 indexed · h-index 15
Topics
Cutaneous lymphoproliferative disorders research (44 papers)Lymphoma Diagnosis and Treatment (32 papers)CAR-T cell therapy research (20 papers)
Partner nations
United StatesItalyFrance

In The Last Decade

Auris Huen

63 papers receiving 831 citations

Peers

Auris Huen
Comparison fields: 5 of 80
  • Dermatology 355
  • Pathology and Forensic Medicine 327
  • Oncology 324
  • Immunology 225
  • Epidemiology 162
Replace Steve Schey with:
Steve Schey United Kingdom
Jeane P. Hester United States
Benedetta Terziroli Beretta‐Piccoli Switzerland
É. Bégon France
Hanyun Ren China
Omar Pacha United States
Voigt Jj France
Nicolas Bachot France
Nikolaus Freudenberg Germany
P. Papanastasiou Switzerland
Auris Huen relative to Steve Schey United Kingdom Steve Schey's profile →
Citations per field
00.5×11.1×
Steve Schey · 1×
Citations per year

Countries citing papers authored by Auris Huen

Since Specialization
Citations

This map shows the geographic impact of Auris Huen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Auris Huen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Auris Huen more than expected).

Fields of papers citing papers by Auris Huen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Auris Huen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Auris Huen. The network helps show where Auris Huen may publish in the future.

Co-authorship network of co-authors of Auris Huen

This figure shows the co-authorship network connecting the top 25 collaborators of Auris Huen. A scholar is included among the top collaborators of Auris Huen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Auris Huen. Auris Huen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 0
5 4
6 0
7 4
8 2
9 16
10 14
11 13
12 1
13 22
14 55
15 20
16 1
17 5
18 82
19 2
20 13

About Auris Huen

Auris Huen is a scholar working on Dermatology, Pathology and Forensic Medicine and Oncology, having authored 75 papers that have together received 841 indexed citations. Recurring topics across this work include Cutaneous lymphoproliferative disorders research (44 papers), Lymphoma Diagnosis and Treatment (32 papers) and CAR-T cell therapy research (20 papers). The work is most often cited by research in Dermatology (355 citations), Pathology and Forensic Medicine (327 citations) and Oncology (324 citations). Auris Huen has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Alain H. Rook, Madeleine Duvic, Ellen J. Kim, Michael T. Tetzlaff, Carlos A. Torres‐Cabala, Priyadharsini Nagarajan, Víctor G. Prieto, Jonathan L. Curry, Phyu P. Aung and Ray Hachem. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026